Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 59 Squamous Cell Carcinoma of Head and Neck 32 Carcinoma, Non-Small-Cell Lung 29 Neoplasms 26 Head and Neck Neoplasms 26 Colonic Neoplasms 20 Neoplasm Metastasis 17 Rectal Neoplasms 12 Breast Neoplasms 11 Lung Neoplasms 10 Pancreatic Neoplasms 9 Carcinoma, Squamous Cell 6 Tongue Neoplasms 5 Salivary Gland Neoplasms 5 Melanoma 5 Stomach Neoplasms 4 Solid Tumors 4 Ovarian Neoplasms 4 Carcinoma, Renal Cell 4 Advanced Solid Tumor 4 Triple Negative Breast Neoplasms 3 Sarcoma 3 Kidney Neoplasms 3 Endometrial Neoplasms 3 Advanced Cancers 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Recurrence 2 Pharyngeal Neoplasms 2 Neoplasms by Site 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × mCRC × Cetuximab × Clear all

NCT07543471 2026-04-24

PK similarity

Shanghai Henlius Biotech

Phase 1 Not yet recruiting

mCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡